Show simple item record

dc.contributor.authorPaliouras, Athanasios R
dc.contributor.authorMagee, Peter
dc.contributor.authorSahoo, Sudhakar
dc.contributor.authorLeong, Hui Sun
dc.contributor.authorKrebs, Matthew G
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorLovly, CM
dc.contributor.authorGarofalo, Michela
dc.date.accessioned2019-11-19T16:00:55Z
dc.date.available2019-11-19T16:00:55Z
dc.date.issued2019en
dc.identifier.citationPaliouras AR, Magee P, Sahoo S, Leong HS, Krebs MG, Blackhall FH, et al. Transcriptomic overview of EML4-ALK lung cancer cells resistant to ALK inhibitors highlights a vulnerability to CDK inhibitors. Cancer Res. 2019;79(13).en
dc.identifier.doi10.1158/1538-7445.AM2019-4761en
dc.identifier.urihttp://hdl.handle.net/10541/622383
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1158/1538-7445.AM2019-4761en
dc.titleTranscriptomic overview of EML4-ALK lung cancer cells resistant to ALK inhibitors highlights a vulnerability to CDK inhibitorsen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentCRUK MI, University of Manchester, Manchester,en
dc.identifier.journalCancer Researchen


This item appears in the following Collection(s)

Show simple item record